| Literature DB >> 30842986 |
Leyla Saeednia1, Li Yao2, Kim Cluff3, Ramazan Asmatulu1.
Abstract
Injectable thermosensitive hydrogels have been widely investigated for drug delivery systems. Chitosan (CH) is one of the most abundant naturalEntities:
Year: 2019 PMID: 30842986 PMCID: PMC6396127 DOI: 10.1021/acsomega.8b03212
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
Figure 1Chitosan/β-GP at room temperature (left) and 37 °C (right).
Figure 2SEM imaging of freeze-dried hydrogels. (A, B) CH−β-GP hydrogel, (C, D) CH−β-GP–CNT (0.1%) hybrid hydrogel, and (E, F) CH−β-GP–CNT (0.5%) hybrid hydrogel. The control (a) and (b) are reproduced from Saeednia et al. with permission from John Wiley and Sons.
Contact Angles and Work of Adhesion of Hybrid Hydrogels
| sample | contact angle (°) | work of adhesion (mJ/m2) |
|---|---|---|
| chitosan | 82 ± 1 | 8.14 |
| CH–CNT 0.1% | 85 ± 2 | 7.80 |
| CH–CNT 0.5% | 89 ± 2 | 7.23 |
Figure 3Characterization of hydrogels. (A) FTIR spectra of CH–CNT (0, 0.1, and 0.5%) hybrid hydrogels. (B) FTIR spectra of CH powder, β-GP powder, and CH−β-GP hydrogel. (C) Raman spectra of CNT and CH–CNT 0.5% hybrid hydrogel. (D) XRD patterns of CH powder, CH hydrogel, and CH–CNT hybrid hydrogel.
Figure 4Swelling and degradation analysis of hydrogels. (A) Swelling ratios of CH−β-GP–CNT (0, 0.1, and 0.5%) hybrid hydrogel. (B, C) Degradation assay of CH−β-GP–CNT (0, 0.1, and 0.5%) hybrid hydrogels.
Figure 5Cell viability assay and cell morphology of cells grown on hydrogels. (A) Cell viability of 3T3 cells grown on CH−β-GP–CNT hybrid hydrogels. (B–D) Fluorescence microscopic images of 3T3 cells labeled with the rhodamine phalloidin and Hoechst. (B) CH−β-GP hydrogel, (C) CH−β-GP–CNT 0.1% hybrid hydrogel, and (D) CH−β-GP–CNT 0.5% hybrid hydrogel. *p < 0.05, compared with the groups of hydrogels containing 0.5% CNT and 1% CNT.
Figure 6Release of methotrexate from CH−β-GP–CNT hybrid hydrogels.
Releasing Rate Constant (k) and Correlation Coefficient (R2) for CH−β-GP–CNT Hybrid Hydrogels
| sample | |||
|---|---|---|---|
| chitosan | 17.3 | 0.18 | 0.998656 |
| CH–CNT 0.1% | 9.0 | 0.17 | 0.999709 |
| CH–CNT 0.5% | 7.6 | 0.17 | 0.999873 |
Figure 7Antitumor efficacy of MTX-loaded CH−β-GP–CNT hybrid hydrogels. *p < 0.05, compared with the group treated with MTX. ∧p < 0.05, compared with the CH-0.5% CNT group. #p < 0.05, compared with the CH-0.5% CNT group.